Other

Asset

MetLife Asset decreased by 14.4% to $392.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 23.7%, from $317.00M to $392.00M. Over 3 years (FY 2022 to FY 2025), Asset shows an upward trend with a 17.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalHigher is better
VolatilityVolatile
First reportedQ4 2021
Last reportedQ1 2026

How to read this metric

An increase indicates higher asset-side backing for market risk guarantees, often correlated with market performance.

Detailed definition

This represents the fair value of assets associated with market risk benefits, which are features in insurance contracts...

Peer comparison

Standard for insurers with variable annuity or market-linked products; peers report this under market risk benefit assets.

Metric ID: other_market_risk_benefit_asset_amount

Historical Data

14 periods
 Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$280.00M$227.00M$279.00M$334.00M$286.00M$351.00M$356.00M$310.00M$372.00M$317.00M$352.00M$392.00M$458.00M$392.00M
QoQ Change-18.9%+22.9%+19.7%-14.4%+22.7%+1.4%-12.9%+20.0%-14.8%+11.0%+11.4%+16.8%-14.4%
YoY Change+2.1%+54.6%+27.6%-7.2%+30.1%-9.7%-1.1%+26.5%+23.1%+23.7%
Range$227.00M$458.00M
CAGR+10.9%
Avg YoY Growth+17.0%
Median YoY Growth+23.4%

Product Breakdown

View all
SegmentQ4 '22
Retirement Assurance$0.00
Total$280.00M

Frequently Asked Questions

What is MetLife's asset?
MetLife (MET) reported asset of $392.00M in Q1 2026.
How has MetLife's asset changed year-over-year?
MetLife's asset increased by 23.7% year-over-year, from $317.00M to $392.00M.
What is the long-term trend for MetLife's asset?
Over 3 years (2022 to 2025), MetLife's asset has grown at a 17.8% compound annual growth rate (CAGR), from $280.00M to $458.00M.
What does asset mean?
The value of assets held to cover market risk protection features in insurance contracts.